Nuclear p27 Expression Confers a Favorable Outcome for Nasopharyngeal Carcinoma Patients

الملخص EN

The purpose of the present study is to explore the correlation between nuclear expression of cyclin-dependent kinase inhibitor 1B (p27) and clinicopathologic features in nasopharyngeal carcinoma (NPC), including patient survival.

Methods.

Immunohistochemistry was used to examine the expression of p27 in 130 primary NPC tissues.

The relationship between the levels of p27 expression and clinicopathologic characteristics was analyzed.

Survival curves were plotted using the Kaplan-Meier method and compared using the log-rank test.

The significance of various survival variables was analyzed using multivariate Cox proportional hazards model.

Results.

p27 was expressed in both nuclear and cytoplasmic compartments.

Nuclear expression of p27 was inversely correlated with T classification and clinical stage.

Patients with nuclear p27 expression had better overall survival rates than those without nuclear expression of p27.

Further, we observed that nuclear expression of p27 was positively associated with survival time of NPC patients not only in N0-1 and M0 classifications but also in radiotherapy and chemotherapy treatment groups.

Finally, we found that nuclear expression of p27 was not an independent prognostic factor for patients with NPC.

Conclusions.

Our findings hint that nuclear expression of p27 is a potentially favorable factor in the progression and prognosis of NPC.